Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Starr

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Cancer Medicine|July 29, 2016
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Ace J Hatch, Alexander B Sibley, Mark D Starr, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 14, 2024
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy ParticipantsYingmiao Liu, Jiatong Li, Jing Lyu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)Andrew B Nixon, Susan Halabi, Yingmiao Liu, et al.
Gynecologic Oncology Reports|June 16, 2025
A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancersStéphanie L Gaillard, Gloria Broadwater, Andrew Berchuck, et al.
Plos One|June 14, 2022
Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemiaSharareh Siamakpour-Reihani, Felicia Cao, Jing Lyu, et al.
Cell Communication and Signaling : CCS|February 15, 2024
Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancerAlex S Choi, Laura M Jenkins-Lane, Wade Barton, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signalingAlex S Choi, Laura M Jenkins-Lane, Wade Barton, et al.
Cell Reports|July 29, 2022
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancerZainab Shonibare, Mehri Monavarian, Kathleen O'Connell, et al.
Science (New York, N.Y.)|October 1, 2011
The major-element composition of Mercury's surface from MESSENGER X-ray spectrometryLarry R Nittler, Richard D Starr, Shoshana Z Weider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Cancer Medicine|July 29, 2016
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Ace J Hatch, Alexander B Sibley, Mark D Starr, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 14, 2024
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy ParticipantsYingmiao Liu, Jiatong Li, Jing Lyu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)Andrew B Nixon, Susan Halabi, Yingmiao Liu, et al.
Gynecologic Oncology Reports|June 16, 2025
A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancersStéphanie L Gaillard, Gloria Broadwater, Andrew Berchuck, et al.
Plos One|June 14, 2022
Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemiaSharareh Siamakpour-Reihani, Felicia Cao, Jing Lyu, et al.
Cell Communication and Signaling : CCS|February 15, 2024
Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancerAlex S Choi, Laura M Jenkins-Lane, Wade Barton, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signalingAlex S Choi, Laura M Jenkins-Lane, Wade Barton, et al.
Cell Reports|July 29, 2022
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancerZainab Shonibare, Mehri Monavarian, Kathleen O'Connell, et al.
Science (New York, N.Y.)|October 1, 2011
The major-element composition of Mercury's surface from MESSENGER X-ray spectrometryLarry R Nittler, Richard D Starr, Shoshana Z Weider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.
Pageof 9